Want to be kept up-to-date? Subscribe to the TrianecT newsletter.
News
Read more XO Ventures and CbusineZ invest €1.35 million in TrianecT to accelerate stroke detection in ambulances
8 July 2025
XO Ventures and CbusineZ invest €1.35 million in TrianecT to accelerate stroke detection in ambulances Utrecht, July 8, 2025 – XO Ventures and CbusineZ are jointly investing €1.35 million in TrianecT BV, an innovative MedTech company specializing in acute stroke diagnostics. The investment will support the commercial development and market launch of StrokePointer™, a portable device that can assess the severity of a stroke while the patient is still in the ambulance.
Read more
Read more UMBRELLA project
1 October 2024
We at TrianecT are excited to announce that we’re part of the UMBRELLA project! This ambitious initiative will revolutionise stroke care across Europe.
Read more
Read more TrianecT is door VGZ genomineerd als "Zorgvernieuwer van de toekomst"
2 September 2024
De nieuwe manier om beroertes te herkennen is door Coöperatie VGZ genomineerd. Help ons om te winnen en stem vandaag nog op TrianecT: https://www.vgz.nl/zorgvernieuwers
Read more
Read more POC4TRIAGE project
1 August 2024
We at TrianecT are excited to announce that we’re part of the POC4TRIAGE project! This innovative project aims to improve point-of-care triage across healthcare.
Read more
Read more Zorg Enablers 2024
21 May 2024
TrianecT is proud to be featured as a Zorg Enabler in 2024! We're honored to be recognized alongside other innovative companies shaping the future of healthcare.
Read more
Read more European Stroke Conference 2024
17 May 2024
TrianecT was present with Wouter Potters, Jonathan Coutinho and Henk Marquering at the European Stroke Conference 2024
Read more
Read more On the front page of V&VN Ambulancezorg
31 December 2023
Late December the groundbreaking ELECTRA-STROKE results from Amsterdam UMC took center stage on the front page of V&VN Ambulancezorg, the premier magazine for ambulance professionals in The Netherlands.
Read more
Read more NWO Take-off 2 awarded
12 December 2023
TrianecT was awarded early-phase funding of € 250.000 by NWO (Dutch Research Council). This additional funding allows TrianecT to accelerate its mission.
Read more
Read more From Academic Knowledge to Societal Impact
1 December 2023
Amsterdam UMC, a leading healthcare provider, educational institution, and research institute, has released a comprehensive position paper outlining its commitment to valorisation, with a primary focus on increasing societal impact. TrianecT is prominently recognized in the paper.
Read more
Read more Installation of board of advisors
19 October 2023
TrianecT today announced the installation of 3 new board advisors. The advisors bring a wealth of experience and expertise in a variety of fields, including the ambulance, insurance and acute stroke field. The new board advisors are: Marjolein Verstappen Martin Smeekes Merel Boers
Read more
Read more Breaking: ELECTRA-STROKE study publication in Neurology
17 October 2023
In a prospective multicenter study, suspected stroke patients were measured in ambulances using the ELECTRA-STROKE brain-wave cap. The results, published in the journal Neurology, show that dry electrode EEG has great potential and high diagnostic accuracy for detecting large vessel occlusion (LVO) stroke in the pre-hospital setting.
Read more
Read more TrianecT featured on ICT&Health
12 October 2022
TrianecT was featured on ICT&health today, the largest health innovation knowledge platform in the Netherlands.
Read more
Read more ELECTRA-STROKE study final inclusion
7 October 2022
With the final and 389th ambulance inclusion the ELECTA-STROKE study was completed in September 2022, a major milestone for TrianecT and Amsterdam UMC. We are looking forward to the results of this ambulance study!
Read more